|
Status |
Public on Dec 10, 2018 |
Title |
MMTV-Neu.176661.Untreated.aCGH |
Sample type |
genomic |
|
|
Channel 1 |
Source name |
DNA reference - UCSC mm7/NCBI release 35 (August 2005)
|
Organism |
Mus musculus |
Characteristics |
characteristics: reference: DNA reference
|
Treatment protocol |
4 different treatments: Untreated, 3 week treatment, 6 week treatment, and Entinostat Progression
|
Extracted molecule |
genomic DNA |
Extraction protocol |
genomic DNA isolated using Dneasy kit (Qiagen)
|
Label |
Cy3
|
Label protocol |
labeled according to the direct incorporation method (Agilent)
|
|
|
Channel 2 |
Source name |
MMTV-Neu.176661.Untreated.aCGH
|
Organism |
Mus musculus |
Characteristics |
cell line: MMTV-Neu treatment: Untreated
|
Treatment protocol |
4 different treatments: Untreated, 3 week treatment, 6 week treatment, and Entinostat Progression
|
Extracted molecule |
genomic DNA |
Extraction protocol |
genomic DNA isolated using Dneasy kit (Qiagen)
|
Label |
Cy5
|
Label protocol |
labeled according to the direct incorporation method (Agilent)
|
|
|
|
Hybridization protocol |
hybridized to Agilent 244k CGH arrays (model G4415A)
|
Scan protocol |
scanned on Agilent scanner (model G2505B)
|
Description |
aCGH
|
Data processing |
Data for both channels were Lowess-normalized and then log(2) ratio was taken
|
|
|
Submission date |
Aug 19, 2018 |
Last update date |
Dec 10, 2018 |
Contact name |
Charles M. Perou |
E-mail(s) |
[email protected]
|
Organization name |
University of North Carolina at Chapel Hill
|
Department |
Professor of Genetics, and Pathology & Laboratory Medicine; Lineberger Comprehensive Cancer Center
|
Street address |
12-044 Lineberger Comprehensive Cancer Center CB# 7295
|
City |
Chapel Hill |
State/province |
NC |
ZIP/Postal code |
27599-7264 |
Country |
USA |
|
|
Platform ID |
GPL4092 |
Series (2) |
GSE118743 |
Identification of Jun loss that promotes resistance to HDAC inhibitor Entinostat through Myc signaling in Luminal breast cancer [CGH] |
GSE118744 |
Identification of Jun loss that promotes resistance to HDAC inhibitor Entinostat through Myc signaling in Luminal breast cancer |
|